Establishment Labs (ESTA) to Release Quarterly Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA) is projected to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.64) per share and revenue of $44.45 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Establishment Labs Price Performance

Shares of NASDAQ:ESTA opened at $35.38 on Wednesday. The company’s fifty day moving average is $38.72 and its two-hundred day moving average is $41.46. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs has a 12-month low of $28.16 and a 12-month high of $60.12. The company has a market cap of $990.64 million, a P/E ratio of -13.71 and a beta of 1.12.

Analyst Ratings Changes

Separately, Stephens upgraded shares of Establishment Labs to a “strong-buy” rating in a report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.